• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Hyderabad, July 5

Suven Life Sciences Ltd will make several data presentations from its portfolio of investigational neuroscience compounds at the International Brain Research Organisation (IBRO) 2007 World Congress of Neuroscience to be held at Melbourne, Australia, during July 12-17. Scientists from Suven Discovery Research will be presenting new data for four promising areas of neuroscience viz. Alzheimer's, Schizophrenia, Parkinson and Obesity diseases. These areas present significant unmet medical need for which current treatment options are insufficient. The Hyderabad-based company has a number of programmes in each of these areas, focusing on novel approaches that may lead to the development of new therapies for patients. The company is presenting the data on their leading preclinical candidates SUVN-502 and SUVN-507 at IBRO 2007. - Our Bureau

More Stories on : Research & Development | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Suven to showcase preclinical data

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line